Competition of SARS-CoV-2 Variants in Cell Culture and Tissue: Wins the Fastest Viral Autowave.
autowaves
competition of viral strains
mathematical modeling and analysis
reaction–diffusion systems
viral infection
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
22 Jun 2022
22 Jun 2022
Historique:
received:
23
05
2022
revised:
13
06
2022
accepted:
14
06
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
28
7
2022
Statut:
epublish
Résumé
Replication of viruses in living tissues and cell cultures is a "number game" involving complex biological processes (cell infection, virus replication inside infected cell, cell death, viral degradation) as well as transport processes limiting virus spatial propagation. In epithelial tissues and immovable cell cultures, viral particles are basically transported via Brownian diffusion. Highly non-linear kinetics of viral replication combined with diffusion limitation lead to spatial propagation of infection as a moving front switching from zero to high local viral concentration, the behavior typical of spatially distributed excitable media. We propose a mathematical model of viral infection propagation in cell cultures and tissues under the diffusion limitation. The model is based on the reaction-diffusion equations describing the concentration of uninfected cells, exposed cells (infected but still not shedding the virus), virus-shedding cells, and free virus. We obtain the expressions for the viral replication number, which determines the condition for spatial infection progression, and for the final concentration of uninfected cells. We determine analytically the speed of spatial infection propagation and validate it numerically. We calibrate the model to recent experimental data on SARS-CoV-2 Delta and Omicron variant replication in human nasal epithelial cells. In the case of competition of two virus variants in the same cell culture, the variant with larger individual spreading speed wins the competition and eliminates another one. These results give new insights concerning the emergence of new variants and their spread in the population.
Identifiants
pubmed: 35891158
pii: vaccines10070995
doi: 10.3390/vaccines10070995
pmc: PMC9317890
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Russian Science Foundation
ID : 22-21-00830
Références
Cardiovasc Drugs Ther. 2021 Apr;35(2):215-229
pubmed: 33074525
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Bioinformatics. 2006 Dec 15;22(24):3067-74
pubmed: 17032683
Cell. 2020 Jul 23;182(2):429-446.e14
pubmed: 32526206
Appl Math Lett. 2022 Nov;133:108217
pubmed: 35669092
Proc Natl Acad Sci U S A. 2021 Jun 22;118(25):
pubmed: 34083352
ACS Omega. 2019 Aug 28;4(11):14430-14438
pubmed: 31528796
Nature. 2022 Mar;603(7902):715-720
pubmed: 35104836
Biophys J. 2012 Nov 21;103(10):2233-40
pubmed: 23200057
Nat Rev Microbiol. 2021 Mar;19(3):155-170
pubmed: 33116300
J Theor Biol. 2018 Nov 14;457:221-236
pubmed: 30170043
Nat Rev Microbiol. 2021 Jul;19(7):425-441
pubmed: 33824495
Biofizika. 1994 Jan-Feb;39(1):89-96
pubmed: 8161593